EMA starts review of Deanxit after reports about side effects

YahooView source article

Part of story

EMA reviews Lundbeck's Deanxit after reports of serious neurological side effects

The European Medicines Agency has begun a safety review of Deanxit, a depression and anxiety medication made by Danish drugmaker H Lundbeck, following reports of serious neurological and psychiatric side effects.

Oct 30, 20262 sourcesMental Health & Wellbeing Adverse event reporting (FAERS)Anxiety and depression Pharmaceutical Industry Drug Policy, Pricing & Approval Drug safety & pharmacovigilance Neurological disorders Anti-depressant

EMA reviews Lundbeck's Deanxit after reports of serious neurological side effects

Other sources for this story

Reuters

EMA starts review of Deanxit after reports about side effects

Part of story

EMA reviews Lundbeck's Deanxit after reports of serious neurological side effects

Other sources for this story

EMA to review Lundbeck's depression, anxiety drug Deanxit after serious side effects reported | Reuters

EMA starts review of Deanxit after reports about side effects

Part of story

EMA reviews Lundbeck's Deanxit after reports of serious neurological side effects

Other sources for this story

EMA to review Lundbeck's depression, anxiety drug Deanxit after serious side effects reported | Reuters